Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06619912

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients

Led by Xijing Hospital · Updated on 2025-07-22

686

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Delirium is a common consequence of cardiac surgery and associates with poor outcomes. Multiple causes can trigger delirium occurence, and it has been hypothesised that sleep disturbances can be one of them. Dexmedetomidine may be effective in reducing delirium. The aim of this study was to demonstrate preoperative dexmedetomidine nasal spray in cardiac surgery patients can reduce postoperative delirium by improving preoperative sleep.

CONDITIONS

Official Title

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 years or older
  • Undergoing cardiac surgery with cardiopulmonary bypass
  • Able to provide consent
Not Eligible

You will not qualify if you...

  • History of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis, neurosurgery, or low Mini-mental State Examination scores
  • Sick sinus syndrome, severe bradycardia (heart rate under 50 beats/min), grade II or higher atrioventricular block without pacemaker
  • Unable to communicate due to coma, severe dementia, or language barriers before surgery
  • Severe liver dysfunction (Child Pugh C), renal dysfunction requiring dialysis, ASA grade V, or expected survival 24 hours or less
  • Heart transplant surgery
  • Surgery for congenital heart disease
  • Deep hypothermic circulatory arrest surgery
  • Currently enrolled in another study
  • Refusal to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xijing Hospital

Xi'an, Shaanxi, China, 710032

Actively Recruiting

Loading map...

Research Team

C

Chong Lei, M.D., phd

CONTACT

Z

Zefei Zhang, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here